Correlation Between ATyr Pharma and Better Therapeutics
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Better Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Better Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Better Therapeutics, you can compare the effects of market volatilities on ATyr Pharma and Better Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Better Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Better Therapeutics.
Diversification Opportunities for ATyr Pharma and Better Therapeutics
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between ATyr and Better is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Better Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Better Therapeutics and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Better Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Better Therapeutics has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Better Therapeutics go up and down completely randomly.
Pair Corralation between ATyr Pharma and Better Therapeutics
Given the investment horizon of 90 days ATyr Pharma is expected to under-perform the Better Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, ATyr Pharma is 1.09 times less risky than Better Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Better Therapeutics is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 136.00 in Better Therapeutics on September 14, 2024 and sell it today you would lose (63.00) from holding Better Therapeutics or give up 46.32% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 39.34% |
| Values | Daily Returns |
ATyr Pharma vs. Better Therapeutics
Performance |
| Timeline |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Better Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ATyr Pharma and Better Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ATyr Pharma and Better Therapeutics
The main advantage of trading using opposite ATyr Pharma and Better Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Better Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Better Therapeutics will offset losses from the drop in Better Therapeutics' long position.| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
| Better Therapeutics vs. ABVC Biopharma | Better Therapeutics vs. Indaptus Therapeutics | Better Therapeutics vs. Pasithea Therapeutics Corp | Better Therapeutics vs. Forte Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |